Month: December 2020
-
Global Vaccine Funds in Covid-19 Relief Bill
The Covid-19 relief bill that the U.S. Congress expects to pass today has more funds for an international group distributing vaccines to low-resource regions.
-
Infographic – Vaccine Support Grows Across Ethnic Lines
A survey this month shows growing acceptance of Covid-19 vaccines across racial and ethnic lines, with Black Americans somewhat less willing than White or Hispanic Americans.
-
Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant
A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin.
-
Large Trial Testing Covid-19 Antibody Therapies
A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections.
-
Fitness, Phone Data Captured for Heart Health Project
A digital health company is partnering with a cardiologist group to capture data from smartphones and wearable devices to provide users personalized heart health information.
-
Neuroscience Biotech Acquired in $770M Deal
A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis.
-
Gates Funding Home-Based Crispr Covid-19 Diagnostic
A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home.
-
Trial Testing Ultrasound, Chemo for Brain Tumors
A clinical trial is underway assessing an implanted ultrasound device with chemotherapy to treat glioblastoma, an aggressive form of brain cancer.
-
ALS Stem Cell Treatments Found Safe, Slow Progression
Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.